• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Focus areas
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Focus areas
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesFocus areasTry Devex Pro
    • News
    • Philanthropy

    Tsitsi Masiyiwa brings local approach to END Fund as new board chair

    Megadonor Tsitsi Masiyiwa lays out her plan for increasing funding to eliminate neglected tropical diseases in Africa as the new board chair of The END Fund.

    By Stephanie Beasley // 04 September 2023
    More than a decade after its founding, a nonprofit that aims to end neglected tropical diseases is working to integrate more African voices into its advocacy for increased funding, new board chair Tsitsi Masiyiwa told Devex. Since 2012, The END Fund, a New York-based collaborative philanthropic fund, has been using the money and influence of its donors — including the Bill & Melinda Gates Foundation, Children’s Investment Fund Foundation, and billionaire MacKenzie Scott — to partner with governments and community health groups to provide treatments for NTDs, which are a group of parasitic and bacterial infectious diseases that disproportionately affect Africans. The END Fund is now working with more experts based on the African continent, which represents a “major shift generally in development and also in the philanthropic community,” Masiyiwa said. Masiyiwa, a Zimbabwean megadonor, stepped in as board chair last month after sitting on the panel for more than six years and filling the role of co-vice chair since 2022. She also is co-founder of both Higherlife Foundation and Delta Philanthropies with her husband Strive, a London-based Zimbawean billionaire businessman and philanthropist. Masiyiwa’s goals as board chair of The END Fund include helping the organization usher in more community voices into its efforts to persuade African governments to commit more resources to fighting NTDs, she told Devex. “Having witnessed the incredible impact of the organisation first-hand, I’m excited to lead our efforts towards even greater sustainability by empowering affected communities to take the lead in eliminating NTDs,” Masiyiwa said in a statement. Nearly 40% of the more than 1.7 billion people affected by NTDs worldwide live in Africa. Those diseases include intestinal worms, river blindness spread by infected black flies, and the contagious eye disease trachoma. “They are diseases that are carried by the poorest of the poor communities,” Masiyiwa told Devex. In communities like these, things like open defecation, which contribute to the spread of infectious diseases, are common, she noted. And it isn’t because people want to engage in such unsanitary behavior. It’s because they are often having to make choices such as installing a toilet or paying to send their children to school, she said. The END Fund’s programs target specific causes such as deworming. Last year, the organization supported the distribution of roughly $550 million worth of NTD treatments and helped fund training for more than 1 million health workers. Its funding plans target specific diseases. Moving forward, the organization wants to make sure “we are sensitive and empathetic to the communities that we are working in and in partnership with to eliminate the diseases,” she said. Masiyiwa also wants to help African governments and the private sector to see the benefits of investing in the elimination of NTDs, which when untreated can prevent people from working and earning a living and can lead to other issues such as food insecurity. “One of the key things that we have to do as The END Fund, and a role that I hope I can play effectively is advocacy and advocacy that is coming from a place of understanding what the challenges and the problems are as opposed to just talking to governments and approaching them in a manner as if they don’t understand what the problem is,” she said. “They understand the problems. There are limited resources. So, how do we collectively find ways of actually allocating budgets for some of these diseases that are neglected?” she said. Countries where The END Fund has successfully helped do that include Rwanda and Ethiopia, Masiyiwa said. But many other African countries do not have actual budgets for NTD prevention and elimination, and that is something that The END Fund wants to help change, she said. “Having offices on the continent and experts on the ground makes the job that much easier,” she said. Collaboration and inclusivity have been key themes in Masiyiwa’s philanthropic work in Africa, which has included being the founding board chair of the African Philanthropy Forum — a network of philanthropists. She is also the lead organizer of the African Gender Initiative, a network of philanthropists that aims to increase gender parity and funding for women-led organizations on the African continent. Gender equity also will be a top priority for Masiyiwa at The END Fund. NTDs affect everyone. However, because women are often the primary source of income in many rural communities, when they are sidelined by a NTD it can have a detrimental effect on entire households, Masiyiwa said. “Part of how I use my voice is bringing that important awareness that we’re not just talking about NTDs because at the center of that is poverty and gender inequality,” she said. Update, Sept. 6, 2023: This story has been updated to clarify strategy changes the END Fund is making on the African continent.

    Related Stories

    RemitHope looks to diaspora giving to fill Africa’s widening funding gap
    RemitHope looks to diaspora giving to fill Africa’s widening funding gap
    Mapping the gaps: The power of data to drive NTD elimination
    Mapping the gaps: The power of data to drive NTD elimination
    Why drug donation programs are a lifeline for NTD elimination efforts
    Why drug donation programs are a lifeline for NTD elimination efforts
    TICAD spotlight: Japan’s pharma commitment to global health
    TICAD spotlight: Japan’s pharma commitment to global health

    More than a decade after its founding, a nonprofit that aims to end neglected tropical diseases is working to integrate more African voices into its advocacy for increased funding, new board chair Tsitsi Masiyiwa told Devex.  

    Since 2012, The END Fund, a New York-based collaborative philanthropic fund, has been using the money and influence of its donors — including the Bill & Melinda Gates Foundation, Children’s Investment Fund Foundation, and billionaire MacKenzie Scott — to partner with governments and community health groups to provide treatments for NTDs, which are a group of parasitic and bacterial infectious diseases that disproportionately affect Africans.

    The END Fund is now working with more experts based on the African continent, which represents a “major shift generally in development and also in the philanthropic community,” Masiyiwa said.

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in

    More reading:

    ► Opinion: The business case for investing in neglected tropical diseases

    ► WASH inclusion in new NTD roadmap signals 'a paradigm shift'

    ► Opinion: Urgent call for integrated approaches to disease elimination

    • Funding
    • Global Health
    • Private Sector
    • Social/Inclusive Development
    • The END Fund
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Stephanie Beasley

      Stephanie Beasley@Steph_Beasley

      Stephanie Beasley is a Senior Reporter at Devex, where she covers global philanthropy with a focus on regulations and policy. She is an alumna of the UC Berkeley Graduate School of Journalism and Oberlin College and has a background in Latin American studies. She previously covered transportation security at POLITICO.

    Search for articles

    Related Stories

    PhilanthropyRelated Stories - RemitHope looks to diaspora giving to fill Africa’s widening funding gap

    RemitHope looks to diaspora giving to fill Africa’s widening funding gap

    Escape the Neglect: Produced in PartnershipRelated Stories - Mapping the gaps: The power of data to drive NTD elimination

    Mapping the gaps: The power of data to drive NTD elimination

    Escape the Neglect: Produced in PartnershipRelated Stories - Why drug donation programs are a lifeline for NTD elimination efforts

    Why drug donation programs are a lifeline for NTD elimination efforts

    Escape the Neglect: Produced in PartnershipRelated Stories - TICAD spotlight: Japan’s pharma commitment to global health

    TICAD spotlight: Japan’s pharma commitment to global health

    Most Read

    • 1
      Building stronger primary care to tackle NCDs and mental health
    • 2
      Collaborating for greater impact — Rwanda’s fight against AMR
    • 3
      Meet the innovators closing persistent gaps in women's health
    • 4
      Investing in opportunity: How venture capital powers social impact
    • 5
      Opinion: AI-powered technologies can transform access to health care
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement